I'm A Patient
I'm A Provider
Delivering a dry AMD diagnosis has always meant offering limited options to your patients. You could provide nutritional guidance, recommend monitoring tools, and schedule follow-up appointments, but you couldn’t address the vision loss they’re already experiencing.
MacuMira changes this reality by offering the first Health Canada-authorized treatment that can improve visual function in dry AMD patients, giving you an active solution instead of passive monitoring.
The Challenge of Traditional Dry AMD Management
Your current dry AMD toolkit focuses entirely on slowing progression rather than improving your patients’ current vision. You monitor for changes, recommend supplements, and prepare patients for potential vision decline, but you often cannot deliver meaningful improvements in their daily visual experience.
Patients may leave your office frustrated with the “wait and watch” approach. People want action, not observation. Meanwhile, you face the difficult reality of having limited tools to support people struggling with reading, driving, or recognizing faces.
This passive management model leaves both you and your patients feeling helpless against a condition that affects nearly 2.5 million Canadians. You deserve treatment options that work, and your patients deserve real hope.
Current Standard Care Approaches and Their Limitations
Traditional dry AMD management relies on prevention strategies that don’t address existing vision problems. These approaches help slow progression but can’t improve the function your patients have already lost.
Nutritional Supplements and Lifestyle Changes
You may recommend AREDS and AREDS2 vitamin formulations to reduce progression risk by about 25%. You can counsel patients about smoking cessation and UV protection while suggesting dietary changes rich in leafy greens and omega-3 fatty acids.
These interventions help prevent further damage but don’t improve the vision problems your patients face today. A patient struggling to read restaurant menus won’t see immediate benefits from taking zinc and antioxidants.
Monitoring and Vision Support Tools
Regular comprehensive eye exams track disease progression, while Amsler grid monitoring helps detect changes between visits. You may refer patients to low-vision specialists for magnifiers and adaptive devices when their central vision deteriorates significantly.
These support tools help patients cope with vision loss but don’t improve their ability to see clearly. You’re managing decline rather than promoting recovery.
MacuMira: A New Treatment Paradigm for Your Practice
MacuMira transforms your dry AMD conversations from managing decline to actively improving vision. You can finally offer patients a treatment that targets their existing visual function problems, not just future progression.
The First Active Treatment Option
This Health Canada-authorized device uses precisely delivered microcurrent to stimulate retinal pigment epithelium cells. The technology enhances mitochondrial activity to support cellular energy production and improve visual function in people living with dry AMD.
Using a headset, your patients experience comfortable, noninvasive 32-minute treatment sessions that deliver gentle stimulation to the closed eyelids.
How MacuMira Works in Your Office
The simple headset delivery system integrates easily into your existing workflow. Patients can relax, listen to music, or even nap during their treatment sessions while the device delivers targeted microcurrent stimulation.
You can schedule treatments alongside regular appointments or dedicate specific time blocks for MacuMira sessions. The noninvasive approach means no recovery time and no restrictions on your patients’ daily activities.
Clinical Results That Transform Patient Outcomes
MacuMira delivers measurable vision improvements that change how your patients experience daily life. Clinical evidence shows consistent, meaningful results across diverse patient populations with dry AMD.
Proven Vision Improvements
Clinical trials demonstrate that 100% of treated patients showed improved visual function. Nearly half achieved clinically significant improvements of 10 or more letters on standard vision charts, with an average gain of 8.2 letters across all participants.
Your patients may notice improved contrast sensitivity, making it easier to distinguish objects from backgrounds. These improvements translate into improved reading ability, safer navigation, and increased confidence in daily activities.
Safety Profile and Patient Experience
Zero adverse events were reported across hundreds of treatment sessions in clinical trials. Patients typically tolerate the gentle microcurrent stimulation well, with many reporting relaxing treatment experiences.
Results often become apparent within the first 10 days of treatment. MacuMira works alongside existing supplements and vision aids, so you don’t need to change your current management strategies.
Implementing MacuMira in Your Eye Care Practice
Adding MacuMira to your practice requires minimal workflow changes while providing comprehensive support for both your team and your patients. The technology integrates smoothly with your existing dry AMD care protocols.
MacuMira provides complete staff training to help your team feel confident operating the device and supporting patients throughout their treatment journey. The user-friendly technology requires minimal technical knowledge to implement effectively.
You receive ongoing clinical support throughout the lifetime of your device, including assistance with patient selection, treatment planning, and outcome tracking. This comprehensive support helps you maximize treatment success.
Your dry AMD patients begin with an initial loading phase of treatments, followed by maintenance sessions every 3 months. This schedule fits naturally into your regular follow-up appointment rhythm, complementing your existing AMD management rather than replacing it.
MacuMira can transform your patient relationships by giving you tools to actively improve vision rather than simply tracking decline. Your patients can leave appointments with renewed optimism about their visual future. You can finally tell dry AMD patients that treatment options exist beyond supplements and lifestyle changes. Regular MacuMira sessions create opportunities for ongoing care discussions while building stronger connections through consistent positive outcomes.
If you would like to learn more about MacuMira, contact us.
